View More
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
From Clinical Care Options (CCO), video featuring expert insights on best practices for nurses within a multidisciplinary CAR T-cell therapy care team
Caron A. Jacobson, MD
Alix Beaupierre, BSN, RN, OCN
Kathleen McDermott, RN, BSN, OCN, BMTCN
Registered Nurses:
2.0 Nursing contact hours
Released: July 8, 2020
Expired: July 7, 2021
Gain key clinical insights fast, with this short slideset from CCO on the optimal use of immune checkpoint inhibitors for RCC
M. Dror Michaelson, MD, PhD
Robert Motzer, MD
Released: July 7, 2020
Gain key clinical insights fast, with this short slideset from CCO on treatment options for patients with urothelial cancer
Daniel P. Petrylak, MD
Matthew I. Milowsky, MD
Jonathan E. Rosenberg, MD
Released: July 7, 2020
Nivolumab plus ipilimumab, with or without chemotherapy, is now approved for advanced NSCLC. Read this expert commentary from CCO on how to best use these regimens in clinical practice.
Stephen V. Liu, MD
Released: July 6, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.